Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Detection & Management of Resistant Hypertension

Hypertension; ePub 2018 Sep 13; Carey, et al

The American Heart Association (AHA) has issued an updated scientific statement on the detection, evaluation, and management of resistant hypertension (RH). Areas covered in the updated statement for diagnosing RH include identifying and correcting medication non-adherence, analyzing whether blood pressures (BPs) have been taken correctly, understanding the white coat effect, and if there is suboptimal antihypertensive therapy being recommended. Among the highlights:

  • Lifestyle factors such as obesity, dietary sodium, alcohol consumption, physical inactivity, and dietary pattern are all linked to RH.
  • Several classes of pharmacologic agents can increase BP and contribute to drug-induced RH, including NSAIDs, oral contraceptives and hormone replacement therapy, and immunosuppressive agents.
  • Evaluation of RH should start with a thorough medical history, physical examination, collection in out-of-office BP monitoring, laboratory evaluation, and non-invasive imaging if warranted.
  • Management of RH incorporates lifestyle interventions and adding exercise to the management regimen. It also includes pharmacological treatment and referral to a hypertension specialist if warranted.


Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: Detection, evaluation, and management. A scientific statement from the American Heart Association. [Published online ahead of print September 13, 2018]. Hypertension. doi:10.1161/HYP.0000000000000084.

This Week's Must Reads

Increased Water Intake in Premenopausal Women with UTIs, JAMA Intern Med; ePub 2018 Oct 1; Hooton, et al

Adverse Childhood Experiences & Weight Status, J Pediatr; ePub 2018 Oct 1; Davis, Barnes, et al

Prevalence of E-Cigarette Use Among US Adults, Ann Intern Med; 2018 Oct 2; Mirbolouk, et al

Continuous Combined Oral Contraceptives & VTE Risk, JAMA Intern Med; ePub 2018 Oct 1; Li, et al

Wearable Cardioverter-Defibrillator Use After MI, N Engl J Med; 2018 Sep 27; Olgin, et al

Must Reads in Cardiology

Wearable Cardioverter-Defibrillator Use After MI, N Engl J Med; 2018 Sep 27; Olgin, et al

Subjective Wellbeing and Cardiometabolic Health, BMJ; ePub 2018 Sep 25; Wootton, et al

Does Aspirin Prevent CV Events in Older Adults?, N Engl J Med; ePub 2018 Sep 16; McNeil, et al

Intensification of BP Treatment Upon Discharge, BMJ; ePub 2018 Sep 12; Anderson, Wray, et al

Detection & Management of Resistant Hypertension, Hypertension; ePub 2018 Sep 13; Carey, et al